Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Resected Pancreatic Adenocarcinoma”

132 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 132 results

Testing effectiveness (Phase 2)UnknownNCT02863471
What this trial is testing

Study on Hyperthermic Intraperitoneal Chemotherapy After Resection of Pancreascarcinoma

Who this might be right for
Adenocarcinomas of the Pancreas
University Hospital Tuebingen 16
Not applicableStudy completedNCT06461598
What this trial is testing

Signature for Precise Chemosensitivity Prediction in PDAC

Who this might be right for
Pancreatic Cancer
Ruijin Hospital 365
Not applicableLooking for participantsNCT02757859
What this trial is testing

High Volume Washing of the Abdomen in Increasing Survival After Surgery in Patients With Pancreatic Cancer That Can Be Removed by Surgery

Who this might be right for
Acinar Cell CarcinomaAmpulla of Vater AdenocarcinomaCholangiocarcinoma+5 more
Sidney Kimmel Cancer Center at Thomas Jefferson University 845
Early research (Phase 1)Ended earlyNCT00003434
What this trial is testing

Biological Therapy in Stage I, Stage II, or Stage III Surgically Resected Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Duke University 8
Testing effectiveness (Phase 2)Ended earlyNCT06069778
What this trial is testing

Safety, Tolerability, and Efficacy of mFOLFIRINOX ± BNT321 as Adjuvant Therapy Following Curative Resection in Patients With Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Cancer
BioNTech SE 1
Testing effectiveness (Phase 2)Study completedNCT02023021
What this trial is testing

Nab-paclitaxel Combined With Gemcitabine as Adjuvant Therapy for Pancreatic Cancer After Curative Resection

Who this might be right for
Stage IA Pancreatic AdenocarcinomaStage IB Pancreatic AdenocarcinomaStage IIA Pancreatic Adenocarcinoma+1 more
Xian-Jun Yu 80
Testing effectiveness (Phase 2)WithdrawnNCT03038477
What this trial is testing

Durvalumab in Patients With BR PDA Following Neoadjuvant Therapy and Successful Surgical Resection

Who this might be right for
Pancreatic Cancer
University of Colorado, Denver
Testing effectiveness (Phase 2)Study completedNCT00660699
What this trial is testing

A Feasibility Phase II Study in the Treatment of Resected Cholangiocarcinoma, Gallbladder, Pancreatic and Ampullary Cancers

Who this might be right for
Cholangiocarcinoma CancerGallbladder CancerPancreatic Cancer+1 more
Washington University School of Medicine 50
Not applicableNot Yet RecruitingNCT06381882
What this trial is testing

The Role of the Human Microbiome in Patients After Pancreatic Resection.

Who this might be right for
Pancreas CancerPancreas NeoplasmPancreas Adenocarcinoma+3 more
St. Antonius Hospital 200
Testing effectiveness (Phase 2)Study completedNCT03801915
What this trial is testing

Perioperative MVT-5873, a Fully Human Monoclonal Antibody Against a CA 19-9 Epitope, for Operable CA 19-9 Producing Pancreatic Cancers, Cholangiocarcinomas, and Metastatic Colorectal Cancers

Who this might be right for
Colon CancerPancreatic CancerCholangiocarcinoma+2 more
National Cancer Institute (NCI) 10
Testing effectiveness (Phase 2)Study completedNCT01553019
What this trial is testing

Postoperative Proton Radiotherapy With Chemo for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
University of Florida 2
Not applicableLooking for participantsNCT04571294
What this trial is testing

Para-aortic Lymphnodes Removal During Upfront Pancreaticoduodenectomy

Who this might be right for
Pancreas CancerPancreaticoduodenal LymphadenopathyPancreas Adenocarcinoma
Humanitas Hospital, Italy 180
Testing effectiveness (Phase 2)Study completedNCT03161379
What this trial is testing

GVAX Pancreas Vaccine (With CY) in Combination With Nivolumab and SBRT for Patients With Borderline Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 31
Testing effectiveness (Phase 2)WithdrawnNCT02310971
What this trial is testing

Cvac as Maintenance Treatment Patients With Resected Stage I or Stage II Adenocarcinoma (Cancer) of the Pancreas

Who this might be right for
Pancreatic Carcinoma Stage IPancreatic Carcinoma Stage II
Prima BioMed Ltd
Early research (Phase 1)Study completedNCT02685553
What this trial is testing

Near Infrared Technology and Laparoscopic Resection of Pancreatic Lesions: the COLPAN Project

Who this might be right for
Pancreatic Neuroendocrine TumorsClear Cell Renal CarcinomaSolid Pseudopapillary Tumors of the Pancreas
Universita di Verona 10
Not applicableEnrolling By InvitationNCT07241676
What this trial is testing

Early Recurrence After Surgery for Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)Recurrent Pancreatic Adenocarcinoma
Azienda Ospedaliera di Padova 500
Large-scale testing (Phase 3)Study completedNCT01526135
What this trial is testing

Trial Comparing Adjuvant Chemotherapy With Gemcitabine Versus mFolfirinox to Treat Resected Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Adenocarcinoma (Ductal Adenocarcinoma)
UNICANCER 493
Early research (Phase 1)Study completedNCT00003025
What this trial is testing

Vaccine Therapy in Treating Patients With Stage I or Stage II Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Memorial Sloan Kettering Cancer Center 16
Large-scale testing (Phase 3)Study completedNCT01964430
What this trial is testing

Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study)

Who this might be right for
Pancreatic NeoplasmsDigestive System NeoplasmsNeoplasms by Site+7 more
Celgene 866
Testing effectiveness (Phase 2)Looking for participantsNCT05968326
What this trial is testing

The Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected PDAC

Who this might be right for
Adenocarcinoma, Pancreatic Ductal
Genentech, Inc. 260
Load More Results